Regulacje i polityka gospodarcza · 18/12/2014
NIH Seeks Exclusive License for Multivalent Vaccines Against Rabies and Filoviruses
The National Institutes of Health is seeking an exclusive license to practice multivalent vaccines for rabies virus and filoviruses, including Ebola and Marburg, from Exxell BIO, Inc., a Minnesota-based company.